Solaris Endovascular today announced its formation to develop solutions for dialysis access and treating peripheral artery ...

Heart disease is expected to affect 61% of US adults by 2050, so it’s important to know when problems may be afoot.

Philips has now developed a device intended to integrate two forms of laser-based PAD therapy, atherectomy and intravascular ...

Learn about Peripheral Artery Disease (PAD) and its impact on the Black community. Discover the risks, symptoms, and treatment options for this irreversible medical condition.

Abbott has delivered new, longer-term data from a clinical study of its dissolving stent for severe peripheral artery disease ...

Peripheral artery disease, or PAD, is a condition that can cause blood flow in your limbs to become restricted or even ...

Solaris Endovascular, Inc. proudly announces its formation to develop solutions for Dialysis Access and Peripheral Artery disease (PAD). Solaris Endovascular develops evidence-based technologies, ...

Cardiovascular disease, sometimes abbreviated as CVD, is the leading cause of death worldwide. It’s a catchall term for heart ...

NEW HOPE, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact ...

GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or weight loss, may reduce the risk of heart attack, second strokes and death ...

This is the first hospital in North Texas to offer the treatment for patients suffering from complex peripheral artery ...

These included age, sex, smoking status, hypertension status, Type 2 diabetes status, peripheral artery disease, ...